AnaptysBioANAB
那斯達克 · USD
45.78
+0.83
(+1.85%)
收盤 12/12 04:59 (UTC+8)
12/12 04:59 (UTC+8)
AnaptysBioANAB
45.78
+0.83
(+1.85%)
財務數據
損益表
- 0.03
- 0.03
- 0.09
- 0.07
- 0.11
- 0.30
- 0.43
- 0.28
- 0.22
- 0.76
- 151.82
- -4.10
- 171.40
- -20.28
- 52.82
- 173.60
- 43.63
- -35.59
- -19.83
- 242.81
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | |
營業收入淨額 | 76,320 | 22,263 | 27,771 | 43,113 | 30,017 | 10,971 | 7,179 | 9,005 | 3,318 | 3,460 |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | 76,320 | 22,263 | 27,771 | 43,113 | 30,017 | 10,971 | 7,179 | 9,005 | 3,318 | 3,460 |
營業費用 | 41,616 | 48,433 | 55,310 | - | 52,774 | - | - | 51,140 | 41,050 | 43,603 |
研發費用 | 31,407 | 37,824 | 41,180 | 42,589 | 42,212 | 41,997 | 37,042 | 33,525 | 30,878 | 32,923 |
推銷及管理費用 | 10,209 | 10,609 | 14,130 | 10,194 | 10,562 | 9,295 | 12,338 | 10,276 | 10,172 | 10,680 |
非經常性項目費用 | - | - | - | - | - | - | - | 7,339 | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | 34,704 | -26,170 | -27,539 | -9,670 | -22,757 | -40,321 | -42,201 | -42,135 | -37,732 | -40,143 |
其他收入及費用 | 2,924 | 7,185 | 6,315 | 5,284 | 5,319 | 4,623 | 4,582 | 4,878 | 4,855 | 4,656 |
利息費用 | 22,515 | 19,606 | 18,061 | 17,404 | 15,413 | 10,953 | 6,317 | 4,958 | 4,431 | 4,358 |
稅前純益 | 15,113 | -38,591 | -39,285 | -21,790 | -32,851 | -46,651 | -43,936 | -42,215 | -37,308 | -39,845 |
所得稅 | - | 39 | 44 | -6 | - | 9 | - | -4 | - | - |
稅後純益 | 15,113 | -38,630 | -39,329 | -21,784 | -32,851 | -46,660 | -43,936 | -42,211 | -37,308 | -39,845 |
基本每股稅後盈餘(元) | 0.54 | -1.34 | -1.28 | -0.72 | -1.14 | -1.71 | -1.64 | - | -1.41 | -1.50 |
稀釋每股稅後盈餘(元) | 0.46 | -1.34 | -1.28 | -0.66 | -1.11 | -1.71 | -1.64 | -1.59 | -1.41 | -1.50 |
基本平均股數(千股) | 27833.00 | 28810.00 | 30644.00 | 30448.00 | 28893.00 | 27356.00 | 26801.00 | - | 26546.00 | 26629.00 |
稀釋平均股數(千股) | 29018.00 | 28810.00 | 30644.00 | 30448.00 | 28893.00 | 27356.00 | 26801.00 | - | 26546.00 | 26629.00 |
還原基本每股稅後盈餘(元) | 0.54 | -1.34 | -1.28 | -0.72 | -1.14 | -1.71 | -1.64 | - | -1.41 | -1.50 |
還原稀釋每股稅後盈餘(元) | 0.46 | -1.34 | -1.28 | -0.66 | -1.11 | -1.71 | -1.64 | -1.59 | -1.41 | -1.50 |
還原基本平均股數(千股) | 27,833 | 28,810 | 30,644 | 30,448 | 28,893 | 27,356 | 26,801 | - | 26,546 | 26,629 |
還原稀釋平均股數(千股) | 29,018 | 28,810 | 30,644 | 30,448 | 28,893 | 27,356 | 26,801 | - | 26,546 | 26,629 |
EBITDA(千元) | 37,108 | -19,981 | -22,285 | -6,087 | -19,408 | -37,580 | -39,982 | -39,807 | -35,278 | -37,083 |